Ypsomed Holding AG (SWX: YPSN)
Switzerland
· Delayed Price · Currency is CHF 326.50
-35.00 (-9.68%)
Dec 20, 2024, 5:30 PM CET
Ypsomed Holding AG Revenue
Ypsomed Holding AG had revenue of 324.01M CHF in the half year ending September 30, 2024, with 32.66% growth. This brings the company's revenue in the last twelve months to 617.07M, up 21.33% year-over-year. In the fiscal year ending March 31, 2024, Ypsomed Holding AG had annual revenue of 548.46M with 10.25% growth.
Revenue (ttm)
617.07M
Revenue Growth
+21.33%
P/S Ratio
7.22
Revenue / Employee
237.34K
Employees
2,296
Market Cap
4.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 548.46M | 51.00M | 10.25% |
| Mar 31, 2023 | 497.46M | 32.62M | 7.02% |
| Mar 31, 2022 | 464.84M | 61.19M | 15.16% |
| Mar 31, 2021 | 403.66M | 9.39M | 2.38% |
| Mar 31, 2020 | 394.26M | -59.50M | -13.11% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 60.58B |
| Roche Holding AG | 60.58B |
| Novartis AG | 42.18B |
| Lonza Group AG | 6.70B |
| Galderma Group AG | 3.88B |
| Straumann Holding AG | 2.54B |
| Sonova Holding AG | 3.71B |
| Galenica AG | 3.80B |
Ypsomed Holding AG News
- 4 weeks ago - Novo Nordisk (NVO) Partners with Ypsomed for Next-Gen Obesity Drug Delivery - GuruFocus
- 4 weeks ago - Novo Nordisk said to have contracted Ypsomed to make next gen obesity drug’s pens - Seeking Alpha